Camallergy
UK - CambridgeBiotechnology
Focus: Camallergy is a UK-based biotechnology company specializing in allergy immunotherapy, positioned in the metabolic diseases therapeutic area. The company operates from Cambridge with limited publicly available scale information.
Profile data last refreshed 3h ago · AI intelligence enriched 2w ago
Open Jobs
0
About Camallergy
AI assessmentNot HiringNo open roles listed right now. Follow Camallergy to get notified when they start hiring — the background below is worth knowing for when they do.
Why Work Here
Data completeness
2/9 — Limited
Company HealthSolid
Pipeline
Early-stage
0 total
LOE Risk
1 in 5yr
SUPRENZA
Hiring
0 open
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Key Products
Post-LOE
Generic amphetamine-derivative with post-LOE status indicates commodity market exposure with minimal differentiation or margin protection.
Help build intelligence for Camallergy
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.